tiprankstipranks
Advertisement
Advertisement

HK:1530 Stock Latest News

3SBio Calls Extraordinary Meeting to Approve Mandi Spin-Off Dividend
Company Announcements3SBio Calls Extraordinary Meeting to Approve Mandi Spin-Off Dividend
8d ago
3SBio Proposes HKD 0.25 Final Dividend for 2025 Financial Year
PremiumCompany Announcements
3SBio Proposes HKD 0.25 Final Dividend for 2025 Financial Year
10d ago
3SBio Plans Conditional Spin-Off Dividend via Mandi Inc. Share Distribution
PremiumCompany Announcements
3SBio Plans Conditional Spin-Off Dividend via Mandi Inc. Share Distribution
10d ago
3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady
PremiumCompany Announcements
3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady
10d ago
3SBio Sets March Board Meeting to Approve 2025 Results and Weigh Mandi Spin-Off Payout
PremiumCompany Announcements
3SBio Sets March Board Meeting to Approve 2025 Results and Weigh Mandi Spin-Off Payout
23d ago
3SBio Completes Share Placement to Boost R&D and Global Expansion
PremiumCompany Announcements3SBio Completes Share Placement to Boost R&D and Global Expansion
4M ago
3SBio Announces Strategic Share Placement to Raise HK$3 Billion
Premium
Company Announcements
3SBio Announces Strategic Share Placement to Raise HK$3 Billion
4M ago
3SBio Announces Proposed Spin-Off and Listing of Mandi Inc.
Premium
Company Announcements
3SBio Announces Proposed Spin-Off and Listing of Mandi Inc.
5M ago
3SBio Subsidiary Mandi Inc. Issues Shares Under Equity Incentive Plan
PremiumCompany Announcements
3SBio Subsidiary Mandi Inc. Issues Shares Under Equity Incentive Plan
6M ago
3SBio’s Strategic Alliance with Pfizer and Promising Growth Potential Justify Buy Rating
PremiumRatings
3SBio’s Strategic Alliance with Pfizer and Promising Growth Potential Justify Buy Rating
7M ago
3SBio’s Promising Future: Buy Rating Backed by Financial Gains and Innovative Drug Pipeline
PremiumRatings
3SBio’s Promising Future: Buy Rating Backed by Financial Gains and Innovative Drug Pipeline
7M ago
3SBio, Inc. Reports Strong Net Profit Growth
PremiumCompany Announcements
3SBio, Inc. Reports Strong Net Profit Growth
7M ago
3SBio Reports Increased Profits Despite Revenue Dip in H1 2025
PremiumCompany Announcements3SBio Reports Increased Profits Despite Revenue Dip in H1 2025
7M ago
3SBio Inc. Schedules Board Meeting to Review Interim Results and Dividend
Premium
Company Announcements
3SBio Inc. Schedules Board Meeting to Review Interim Results and Dividend
8M ago
3SBio Completes Share Subscription with Pfizer, Raising HK$785 Million
Premium
Company Announcements
3SBio Completes Share Subscription with Pfizer, Raising HK$785 Million
8M ago
3SBio and Pfizer Finalize License Agreement and Share Subscription
PremiumCompany Announcements
3SBio and Pfizer Finalize License Agreement and Share Subscription
9M ago
3SBio Inc. Announces AGM Results, Dividend Payment, and Committee Changes
PremiumCompany Announcements
3SBio Inc. Announces AGM Results, Dividend Payment, and Committee Changes
10M ago
3SBio Announces Board Roles and Functions
PremiumCompany Announcements
3SBio Announces Board Roles and Functions
10M ago
3SBio Inc. Updates Nomination Committee Terms of Reference
PremiumCompany Announcements
3SBio Inc. Updates Nomination Committee Terms of Reference
10M ago
3SBio Inc. Announces Annual General Meeting with Key Resolutions
PremiumCompany Announcements3SBio Inc. Announces Annual General Meeting with Key Resolutions
11M ago
Pfizer Signs $6B Deal with 3SBio for China-Based Cancer Drug
Premium
Market News
Pfizer Signs $6B Deal with 3SBio for China-Based Cancer Drug
11M ago
PFE
3SBio Partners with Pfizer for Global Licensing of Oncology Antibody
Premium
Company Announcements
3SBio Partners with Pfizer for Global Licensing of Oncology Antibody
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >